U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07693543) titled 'Nicotinamide Riboside Supplementation in Chronic Kidney Disease' on June 29.
Brief Summary: This study is testing whether a dietary supplement called nicotinamide riboside, (NR), can be used in adults with moderate chronic kidney disease. NR is a form of vitamin B3 that may help support cellular energy metabolism.
The main goal of this study is to see whether it is feasible for people with chronic kidney disease to take NR daily, complete study visits, and follow the study procedures. The study will also explore whether NR chloride affects markers of mitochondrial health, small blood vessel function, and physical function.
Partici...